Recent blog posts
NCT07627906 Propofol/Ketamine Hydrochloride Emergence Delirium Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07627906 Propofol/Ketamine Hydrochloride Emergence Delirium Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07627906 clinical trial report covering Propofol/Ketamine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space
Read →
NCT07625774 Safiglipron Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07625774 Safiglipron Chronic Kidney Diseases Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07625774 clinical trial report covering Safiglipron, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07626411 REGN-7508 Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07626411 REGN-7508 Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07626411 clinical trial report covering REGN-7508, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07625306 Pelacarsen Acute Coronary Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07625306 Pelacarsen Acute Coronary Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07625306 clinical trial report covering Pelacarsen, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07630779 Inositol Diabetes Mellitus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07630779 Inositol Diabetes Mellitus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07630779 clinical trial report covering Inositol, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07628504 Sacituzumab tirumotecan Drug adjuvant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07628504 Sacituzumab tirumotecan Drug adjuvant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07628504 clinical trial report covering Sacituzumab tirumotecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07629440 Multivalent Pneumococcal Conjugate Vaccine(Pfizer) Pneumococcal Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07629440 Multivalent Pneumococcal Conjugate Vaccine(Pfizer) Pneumococcal Infections Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07629440 clinical trial report covering Multivalent Pneumococcal Conjugate Vaccine(Pfizer), Phase 3, endpoints, sponsor, geography, readout timing and deve
Read →
ChiCTR2600126202 Eltrombopag Diolamine Acute Myeloid Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
ChiCTR2600126202 Eltrombopag Diolamine Acute Myeloid Leukemia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600126202 clinical trial report covering Eltrombopag Diolamine, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07629817 Albumin-Bound Paclitaxel Esophageal Squamous Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07629817 Albumin-Bound Paclitaxel Esophageal Squamous Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07629817 clinical trial report covering Albumin-Bound Paclitaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07629544 DA-302168S Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07629544 DA-302168S Obesity Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07629544 clinical trial report covering DA-302168S, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
NCT07628985 Bofanglutide Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
NCT07628985 Bofanglutide Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07628985 clinical trial report covering Bofanglutide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
CTR20262117 JYP-0061 Dermatitis, Atopic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
Latest Hotspot
8 min read
CTR20262117 JYP-0061 Dermatitis, Atopic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262117 clinical trial report covering JYP-0061, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →